HLA class I and class II expression of pulmonary adenocarcinoma cells and the influence of interferon gamma

Tokujiro Yano, Yasuro Fukuyama, Hideki Yokoyama, Shinji Kuninaka, Hiroshi Asoh, Yasaburo Katsuda, Yukito Ichinose

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: The clinico-biological significance of HLA (both class I antigen and class II one) expressed on tumor cells still remains controversial. Methods: Tumor cells were freshly separated from 33 surgical specimens of pulmonary adenocarcinoma. The tumor cells were incubated for 24 h in the presence or absence of IFN-γ (130 International Units/ml). After incubation, the cells were cytocentrifuged onto glass slides and immunostained with either an anti-HLA class I (A, B, C) monoclonal antibody or anti-HLA class II (DR) one. Results: In 22 of 33 cases (66.7%), the HLA class I were individually expressed by more than 60% of tumor cells while so were the HLA class II in 15 (45.4%). No significant correlation was observed between the HLA class I expression and the HLA class II one. The proportion of HLA class I-positive tumor cells correlated with neither the grade of histological differentiation nor the stage of disease. In contrast, the proportion of HLA class II-positive tumor cells correlated with both the grade of histological differentiation and the stage. In most cases, IFN-γ was found to increase the proportion of class II-positive tumor cells as well as that of class I-positive cells. Conclusions: The above findings thus suggested that the HLA class II expression might therefore represent a manifestation of cellular differentiation and that IFN-γ may, as a result, have the potential to differentiate cancer cells. Copyright (C) 1998 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)185-190
Number of pages6
JournalLung Cancer
Volume20
Issue number3
DOIs
Publication statusPublished - 1998 Jun
Externally publishedYes

Fingerprint

Interferon-gamma
Neoplasms
Adenocarcinoma of lung
Histocompatibility Antigens Class I
Glass
Monoclonal Antibodies

Keywords

  • Differentiation
  • HLA class I
  • HLA class II
  • IFN-γ
  • Immunocytochemistry
  • Pulmonary adenocarcinoma
  • Stage of the disease

ASJC Scopus subject areas

  • Oncology

Cite this

Yano, T., Fukuyama, Y., Yokoyama, H., Kuninaka, S., Asoh, H., Katsuda, Y., & Ichinose, Y. (1998). HLA class I and class II expression of pulmonary adenocarcinoma cells and the influence of interferon gamma. Lung Cancer, 20(3), 185-190. https://doi.org/10.1016/S0169-5002(98)00010-5

HLA class I and class II expression of pulmonary adenocarcinoma cells and the influence of interferon gamma. / Yano, Tokujiro; Fukuyama, Yasuro; Yokoyama, Hideki; Kuninaka, Shinji; Asoh, Hiroshi; Katsuda, Yasaburo; Ichinose, Yukito.

In: Lung Cancer, Vol. 20, No. 3, 06.1998, p. 185-190.

Research output: Contribution to journalArticle

Yano, T, Fukuyama, Y, Yokoyama, H, Kuninaka, S, Asoh, H, Katsuda, Y & Ichinose, Y 1998, 'HLA class I and class II expression of pulmonary adenocarcinoma cells and the influence of interferon gamma', Lung Cancer, vol. 20, no. 3, pp. 185-190. https://doi.org/10.1016/S0169-5002(98)00010-5
Yano, Tokujiro ; Fukuyama, Yasuro ; Yokoyama, Hideki ; Kuninaka, Shinji ; Asoh, Hiroshi ; Katsuda, Yasaburo ; Ichinose, Yukito. / HLA class I and class II expression of pulmonary adenocarcinoma cells and the influence of interferon gamma. In: Lung Cancer. 1998 ; Vol. 20, No. 3. pp. 185-190.
@article{6de598bfc8b6457e8b814c757d1aee1f,
title = "HLA class I and class II expression of pulmonary adenocarcinoma cells and the influence of interferon gamma",
abstract = "Background: The clinico-biological significance of HLA (both class I antigen and class II one) expressed on tumor cells still remains controversial. Methods: Tumor cells were freshly separated from 33 surgical specimens of pulmonary adenocarcinoma. The tumor cells were incubated for 24 h in the presence or absence of IFN-γ (130 International Units/ml). After incubation, the cells were cytocentrifuged onto glass slides and immunostained with either an anti-HLA class I (A, B, C) monoclonal antibody or anti-HLA class II (DR) one. Results: In 22 of 33 cases (66.7{\%}), the HLA class I were individually expressed by more than 60{\%} of tumor cells while so were the HLA class II in 15 (45.4{\%}). No significant correlation was observed between the HLA class I expression and the HLA class II one. The proportion of HLA class I-positive tumor cells correlated with neither the grade of histological differentiation nor the stage of disease. In contrast, the proportion of HLA class II-positive tumor cells correlated with both the grade of histological differentiation and the stage. In most cases, IFN-γ was found to increase the proportion of class II-positive tumor cells as well as that of class I-positive cells. Conclusions: The above findings thus suggested that the HLA class II expression might therefore represent a manifestation of cellular differentiation and that IFN-γ may, as a result, have the potential to differentiate cancer cells. Copyright (C) 1998 Elsevier Science Ireland Ltd.",
keywords = "Differentiation, HLA class I, HLA class II, IFN-γ, Immunocytochemistry, Pulmonary adenocarcinoma, Stage of the disease",
author = "Tokujiro Yano and Yasuro Fukuyama and Hideki Yokoyama and Shinji Kuninaka and Hiroshi Asoh and Yasaburo Katsuda and Yukito Ichinose",
year = "1998",
month = "6",
doi = "10.1016/S0169-5002(98)00010-5",
language = "English",
volume = "20",
pages = "185--190",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - HLA class I and class II expression of pulmonary adenocarcinoma cells and the influence of interferon gamma

AU - Yano, Tokujiro

AU - Fukuyama, Yasuro

AU - Yokoyama, Hideki

AU - Kuninaka, Shinji

AU - Asoh, Hiroshi

AU - Katsuda, Yasaburo

AU - Ichinose, Yukito

PY - 1998/6

Y1 - 1998/6

N2 - Background: The clinico-biological significance of HLA (both class I antigen and class II one) expressed on tumor cells still remains controversial. Methods: Tumor cells were freshly separated from 33 surgical specimens of pulmonary adenocarcinoma. The tumor cells were incubated for 24 h in the presence or absence of IFN-γ (130 International Units/ml). After incubation, the cells were cytocentrifuged onto glass slides and immunostained with either an anti-HLA class I (A, B, C) monoclonal antibody or anti-HLA class II (DR) one. Results: In 22 of 33 cases (66.7%), the HLA class I were individually expressed by more than 60% of tumor cells while so were the HLA class II in 15 (45.4%). No significant correlation was observed between the HLA class I expression and the HLA class II one. The proportion of HLA class I-positive tumor cells correlated with neither the grade of histological differentiation nor the stage of disease. In contrast, the proportion of HLA class II-positive tumor cells correlated with both the grade of histological differentiation and the stage. In most cases, IFN-γ was found to increase the proportion of class II-positive tumor cells as well as that of class I-positive cells. Conclusions: The above findings thus suggested that the HLA class II expression might therefore represent a manifestation of cellular differentiation and that IFN-γ may, as a result, have the potential to differentiate cancer cells. Copyright (C) 1998 Elsevier Science Ireland Ltd.

AB - Background: The clinico-biological significance of HLA (both class I antigen and class II one) expressed on tumor cells still remains controversial. Methods: Tumor cells were freshly separated from 33 surgical specimens of pulmonary adenocarcinoma. The tumor cells were incubated for 24 h in the presence or absence of IFN-γ (130 International Units/ml). After incubation, the cells were cytocentrifuged onto glass slides and immunostained with either an anti-HLA class I (A, B, C) monoclonal antibody or anti-HLA class II (DR) one. Results: In 22 of 33 cases (66.7%), the HLA class I were individually expressed by more than 60% of tumor cells while so were the HLA class II in 15 (45.4%). No significant correlation was observed between the HLA class I expression and the HLA class II one. The proportion of HLA class I-positive tumor cells correlated with neither the grade of histological differentiation nor the stage of disease. In contrast, the proportion of HLA class II-positive tumor cells correlated with both the grade of histological differentiation and the stage. In most cases, IFN-γ was found to increase the proportion of class II-positive tumor cells as well as that of class I-positive cells. Conclusions: The above findings thus suggested that the HLA class II expression might therefore represent a manifestation of cellular differentiation and that IFN-γ may, as a result, have the potential to differentiate cancer cells. Copyright (C) 1998 Elsevier Science Ireland Ltd.

KW - Differentiation

KW - HLA class I

KW - HLA class II

KW - IFN-γ

KW - Immunocytochemistry

KW - Pulmonary adenocarcinoma

KW - Stage of the disease

UR - http://www.scopus.com/inward/record.url?scp=0031818878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031818878&partnerID=8YFLogxK

U2 - 10.1016/S0169-5002(98)00010-5

DO - 10.1016/S0169-5002(98)00010-5

M3 - Article

C2 - 9733053

AN - SCOPUS:0031818878

VL - 20

SP - 185

EP - 190

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 3

ER -